220 related articles for article (PubMed ID: 32115180)
1. Detailed overview on rare malignant ovarian tumors.
Aust S; Eberst L; Tredan O; Rousset-Jablonski C; Treilleux I; Méeus P; Chopin N; Beurrier F; Charreton A; Véronique D; Hallouz A; Coulon A; Ricoeur A; Mastier C; Bouhamama A; Racadot S; Devouassoux-Shisheboran M; Haddad V; Ray-Coquard I
Bull Cancer; 2020 Mar; 107(3):385-390. PubMed ID: 32115180
[TBL] [Abstract][Full Text] [Related]
2. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
[TBL] [Abstract][Full Text] [Related]
3. Cytopathology of ovarian lesions: the intraoperative approach.
Jiménez-Ayala M; Jiménez-Ayala Portillo B
Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
[No Abstract] [Full Text] [Related]
4. Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis.
Nitecki R; Diver EJ; Kamdar MM; Boruta DM; Del Carmen MC; Clark RM; Goodman A; Schorge JO; Growdon WB
Gynecol Oncol; 2018 Mar; 148(3):521-526. PubMed ID: 29395315
[TBL] [Abstract][Full Text] [Related]
5. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ovarian cancer in young women.
Gershenson DM
Clin Obstet Gynecol; 2012 Mar; 55(1):65-74. PubMed ID: 22343230
[TBL] [Abstract][Full Text] [Related]
7. Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
Jang JYA; Yanaihara N; Pujade-Lauraine E; Mikami Y; Oda K; Bookman M; Ledermann J; Shimada M; Kiyokawa T; Kim BG; Matsumura N; Kaku T; Kuroda T; Nagayoshi Y; Kawabata A; Iida Y; Kim JW; Quinn M; Okamoto A
J Gynecol Oncol; 2017 Jul; 28(4):e54. PubMed ID: 28541641
[TBL] [Abstract][Full Text] [Related]
8. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects.
Boussios S; Moschetta M; Zarkavelis G; Papadaki A; Kefas A; Tatsi K
Crit Rev Oncol Hematol; 2017 Dec; 120():43-51. PubMed ID: 29198337
[TBL] [Abstract][Full Text] [Related]
9. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
Mutch DG; Prat J
Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
[No Abstract] [Full Text] [Related]
10. [Pathology of ovarian cancer].
Kaku T; Watanabe S; Ohishi Y
Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
[No Abstract] [Full Text] [Related]
11. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
12. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J
Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in ovarian cancer.
Scully RE
Hum Pathol; 1970 Mar; 1(1):73-98. PubMed ID: 4330995
[No Abstract] [Full Text] [Related]
14. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
Hazard FK; Longacre TA
Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
Skírnisdóttir I; Seidal T
Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
[TBL] [Abstract][Full Text] [Related]
16. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Chabbert-Buffet N; Daraï E; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; de la Motte Rouge T; Ferron G; Devouassoux-Shisheboran M; Kurtz JE; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
Bull Cancer; 2018 Mar; 105(3):299-314. PubMed ID: 29397916
[TBL] [Abstract][Full Text] [Related]
17. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
[TBL] [Abstract][Full Text] [Related]
18. Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Loh SH; Chen A; Yao CW; Yen CY
Mod Pathol; 2006 Mar; 19(3):447-52. PubMed ID: 16439987
[TBL] [Abstract][Full Text] [Related]
19. Value of inhibin in the identification of granulosa cell tumors of the ovary.
Hildebrandt RH; Rouse RV; Longacre TA
Hum Pathol; 1997 Dec; 28(12):1387-95. PubMed ID: 9416696
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
